Trial of Ondansetron as a Parkinson's HAllucinations Treatment

Condition:   Parkinson's Hallucinations Intervention:   Drug: Ondansetron 8mg or matched placebo Sponsors:   University College, London;   MODEPHARMA Limited;   PARKINSONS UK;   PRIMENT;   SEALED ENVELOPE;   Wasdell Packaging Ltd;   Custom Pharmaceuticals Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials